News
Artificial intelligence, technology, science, health and education — reported daily, with the original source attached to every item.
6 stories
Two Nature Medicine Trials of a Multi-Cancer Blood Test Reach Different Verdicts on the Same Day
Published the same day in Nature Medicine, PATHFINDER 2 and the NHS-Galleri trial reach different verdicts on GRAIL's Galleri blood test: strong predictive value in a single-arm US-Canada cohort, but a missed primary endpoint in a 142,250-person randomized UK trial.
Single-Infusion In Vivo CAR T-Cell Therapy Eases Four Neurologic Autoimmune Diseases in Small NEJM Trial
A 16-patient trial published in NEJM on September 3, 2026 tested a single-infusion lentiviral vector that generates CD19 CAR T cells inside…
First International Consensus Guideline for Personalized Phage Therapy Published in Nature Medicine
An international working group coordinated by Germany's DGI has published the first consensus guideline for personalized bacteriophage ther…
A Common Epilepsy Drug Is Linked to Longer Survival in an Almost Untreatable Childhood Brain Tumor
A retrospective Nature Medicine study (Sept. 17, 2026) led by Stanford Medicine finds children with diffuse midline glioma survived longer …
A Blood-Based Score Combining Ten microRNAs and CA19-9 Flags Early Pancreatic Cancer in a 1,785-Person Study
A prospective 1,785-person study published in Nature Medicine on September 16, 2026, found that PANXEON — a blood test combining ten microR…
Phase 1 Trial Finds a Cancer-Style T-Cell Engager Can Push Refractory Lupus Into Remission
A phase 1 trial of A-319, a CD3×CD19 bispecific antibody adapted from cancer therapy, pushed most of 12 treatment-resistant lupus patients …